Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Vitrolife ADR VTRLY

Healthcare Biotechnology

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

PINL:VTRLY - Post by User

Vitrolife ADR

Bullboard Posts

Post by ivosmithon Dec 14, 2023 2:56am

74 Views

Post# 35783764

Male Infertility Market to reach US$ 5.2 Billion by 2032

According to the latest research report, the global male infertility market size reached US$ 3.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.49% during 2024-2032.

Industrial Gloves Market Trends and Drivers:

The trend of postponing parenthood is currently gaining momentum, driven by evolving societal norms and career aspirations. Nevertheless, advancing age is linked to a decline in male fertility, encompassing reduced sperm quality and heightened DNA fragmentation. This trend has led to an increase in age-related fertility challenges among men, sparking a growing demand in the male infertility market for fertility preservation and treatment options. Older men, aspiring to start families later in life, are particularly seeking these interventions. This highlights the necessity for specialized solutions addressing the unique requirements of this demographic.

Request a free sample copy of the report: https://www.imarcgroup.com/male-infertility-market/requestsample